Georges Chahine
Overview
Explore the profile of Georges Chahine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AlAyoubi A, Ghattas S, Maalouf H, Chahine G, Kiriakos K, Fares M
Surg J (N Y)
. 2025 Mar;
10(4):e65-e70.
PMID: 40034993
Colonic obstruction is reported in 85% of emergency colorectal surgery for cancer. Colonic ischemia, however, is a rare entity and is found in 5% of these emergency cases. We herein...
2.
Abi Rached V, Azar K, Gerges S, Hallit S, Akoury E, Chahine G, et al.
Access Microbiol
. 2024 Sep;
6(9).
PMID: 39280083
Oesophageal aspergillosis is a rare occurrence primarily documented in hematologic malignancies, and only rarely occurring among patients with solid tumours. In this case report, we present the unique case of...
3.
Rida M, Chalhoub M, Mansour M, Younan T, Chahine G, Nassar J, et al.
Radiol Case Rep
. 2024 Aug;
19(10):4429-4434.
PMID: 39185436
Ectopic hepatocellular carcinoma (HCC) is defined as HCC arising from hepatic parenchyma located in an extrahepatic organ or tissue without any communication with the mother liver. It is very rare...
4.
Ghattas S, Al Bitar J, Chahine G, Kamar F, Haddad M, Wakim R
Case Reports Hepatol
. 2024 Mar;
2024:9181560.
PMID: 38440188
Primary hepatic neuroendocrine tumors (PHNETs) are extremely rare and account for about 0.3% of all neuroendocrine tumor cases. Resection is usually difficult because they are usually diagnosed in the late...
5.
El Toum Y, Costa T, El Toum E, Haddad T, Salameh P, El Karak F, et al.
Support Care Cancer
. 2024 Feb;
32(3):172.
PMID: 38379082
Purpose: This cross-sectional study aimed to investigate the prevalence and characteristics of supplement usage among cancer patients and explore its potential associations with anxiety, excessive daytime sleepiness, and overall quality...
6.
Ayoub G, Sinan H, Kourie H, Kattan J, Nasr F, El Karak F, et al.
Future Oncol
. 2023 Oct;
19(29):1991-2002.
PMID: 37795707
Chronic lymphocytic leukemia (CLL) is a highly heterogenous hemopathy. Genetic stratification of CLL patients has important prognostic and therapeutic values - mainly immunoglobulin heavy chain variable region gene () mutational...
7.
Abdallah R, Atallah D, Bitar N, Chahine G, Ghanem H, Ghosn M, et al.
Gynecol Oncol Rep
. 2023 May;
47:101186.
PMID: 37181681
Ovarian cancer is the most lethal gynecologic cancer. The high grade serous epithelial (HGSE) subtype is the most aggressive and it often presents at advanced stages, while screening programs have...
8.
Hamadeh L, Farhat L, Hilal L, Assi H, Nasr F, Chahine G, et al.
Gene
. 2023 Apr;
871:147433.
PMID: 37068694
The PIK3CA pathway is one of the most frequently altered pathways in human cancers, especially in breast cancer with approximately 40% of HR+/HER2- advanced breast cancer cases exhibiting mutations in...
9.
Hajj A, Salameh P, Khoury R, Hachem R, Sacre H, Chahine G, et al.
Future Oncol
. 2022 Nov;
18(33):3741-3753.
PMID: 36345984
To validate the French version of the 37-item Functional Assessment of Cancer Therapy-Cognitive Function, including the four items related to multitasking, previously excluded from the scoring algorithm. A cross-sectional study...
10.
Kattan J, El Karak F, Farhat F, Gerges D, Mokaddem W, Chahine G, et al.
BMC Cancer
. 2022 Nov;
22(1):1114.
PMID: 36316658
Background: This study aimed to report the prevalence of HER2-neu in newly diagnosed early or metastatic gastric cancer (GC) patients, to determine the percentage of patients achieving various IHC scores...